Optiver Holding
GYRE icon

Optiver Holding’s Gyre Therapeutics GYRE Stock Holding History

Optiver Holding’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$711 Sell
102
-120
-54% -$932 ﹤0.01% 2112
2025
Q4 		$1.57K Hold
222
– – ﹤0.01% 2115
2025
Q3 		$1.66K Buy
+222
New +$1.69K ﹤0.01% 2428

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Optiver Holding's GYRE Position: Q1 2026 in Review

Optiver Holding reduced its Gyre Therapeutics (GYRE) stake by 54% in Q1 2026, selling an estimated $932 and leaving 102 shares worth $711. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Optiver Holding first reported a position in GYRE in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.66K in Q3 2025. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Optiver Holding held 102 shares of Gyre Therapeutics worth $711 as of Q1 2026.
  • Optiver Holding sold 120 Gyre Therapeutics shares in Q1 2026, an estimated $932.
  • Gyre Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2112 holding.
  • Optiver Holding first reported a position in Gyre Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Gyre Therapeutics position peaked at $1.66K in Q3 2025.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.